SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-029396
Filing Date
2021-05-26
Accepted
2021-05-26 17:30:06
Documents
40
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_cmlifescience3.htm 10-Q 246371
2 CERTIFICATION f10q0321ex31-1_cmlife3.htm EX-31.1 13364
3 CERTIFICATION f10q0321ex31-2_cmlife3.htm EX-31.2 13468
4 CERTIFICATION f10q0321ex32-1_cmlife3.htm EX-32.1 5067
5 CERTIFICATION f10q0321ex32-2_cmlife3.htm EX-32.2 4947
  Complete submission text file 0001213900-21-029396.txt   1684516

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cmlt-20210331.xml EX-101.INS 152988
7 XBRL SCHEMA FILE cmlt-20210331.xsd EX-101.SCH 27974
8 XBRL CALCULATION FILE cmlt-20210331_cal.xml EX-101.CAL 12332
9 XBRL DEFINITION FILE cmlt-20210331_def.xml EX-101.DEF 131840
10 XBRL LABEL FILE cmlt-20210331_lab.xml EX-101.LAB 206162
11 XBRL PRESENTATION FILE cmlt-20210331_pre.xml EX-101.PRE 132591
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40312 | Film No.: 21967590
SIC: 6770 Blank Checks